1993
The Cooper Union for the Advancement of Science and Art
B.S. Engineering
Summa Cum Laude · Tau Beta Pi
New Jersey Robotic Urologic Surgeon · Founder, Innovative Urology
Dr. Savatta is a board-certified New Jersey urologist who has performed 3,000 robotic surgeries in two decades of practice, including 2,000 robotic prostatectomies. Innovative Urology presents that experience with verified publication context and holds market-leadership or broadcast claims until exact source proof is attached.
1993
The Cooper Union for the Advancement of Science and Art
B.S. Engineering
Summa Cum Laude · Tau Beta Pi
1997
Stony Brook University School of Medicine
Doctor of Medicine
AOA Honor Society
2003
Indiana University Medical Center
Urology Residency
Internationally recognized for urologic oncology
Dr. Savatta founded Innovative Urology to connect hospital-level urologic judgment with a more organized patient experience. The practice is designed to evaluate the problem first, explain the options clearly, and keep follow-through connected after the visit.
Engineer before medicine
Dr. Savatta's training began at Cooper Union, where he studied engineering before entering medicine. That background supports the way he thinks about surgery, systems, and patient follow-through.
Urologic oncology and robotic surgery
His public biography centers on complex urologic decision-making: prostate cancer, kidney cancer, BPH, robotic surgery, prostate biopsy, stone care, and men's wellness.
Founder-led care model
Innovative Urology is built around a direct physician relationship, organized scheduling, clear records, and care that can move across telehealth, office, hospital, and procedure settings when appropriate.

Where the work happens
3,000
Robotic surgeries performed
The corrected Innovative Urology authority number is 3,000 robotic surgeries across two decades of practice.
2,000
Robotic prostatectomies
The corrected prostatectomy number is 2,000 robotic prostatectomies, used without unsupported market-leadership claims.
2008
Prostatectomy and inguinal hernia publication
A PubMed Central paper lists Dr. Savatta among the authors on robotic-assisted laparoscopic radical prostatectomy with inguinal herniorrhaphy.
2008
Robotic partial nephrectomy publication
A Journal of Robotic Surgery multi-institutional analysis lists D. J. Savatta among the authors on robotic partial nephrectomy outcomes.
Xodus
Savatta Pink Lat Pack source reference
Xodus Medical source material identifies the Savatta Pink Lat Pack. Invention or design credit is held until exact wording is verified.
NJ
Hospital robotic program history
The practice can describe hospital robotic surgery program leadership history while separately source-reviewing any specific milestone claims.
Dr. Savatta has helped establish and grow robotic surgery programs across multiple New Jersey hospitals, bringing robotic urologic care into multiple hospital settings over two decades. Specific milestone wording is kept source-reviewed before it appears in public copy.
2004
Newark Beth Israel
2007
Saint Barnabas Medical Center
2009
Trinitas
2023
Rahway
Innovative Urology is designed as a comprehensive modern urology group: subspecialty depth where it matters, physician extenders supporting medical urology, and a patient experience that stays connected from intake through follow-up. Care runs across telehealth, office, hospital, and procedural settings on one chart and one schedule.
The Men’s Wellness Institute is a subdivision of Innovative Urology focused on the broader men’s-health front door — ED, low testosterone, vasectomy, and the screening conversations most men avoid. It carries the same operating standards as the parent practice.
Languages spoken: English, Italian.
The founding member program is positioned as an access and follow-through model for patients who want a physician-led urology relationship. It is not a shortcut around medical evaluation, insurance rules, or appropriate care setting decisions.
Program availability, terms, covered services, insurance status, and self-pay responsibility are confirmed by the office before scheduling or treatment decisions.
Insurance and self-pay options are reviewed at intake. Confidentiality is the default.
Please do not include medical information in your initial message. We’ll move clinical details to a secure channel after first contact.